Search Results for "establish"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for establish. Results 321 to 330 of 654 total matches.
A New Long-acting Methylphenidate (Concerta)
The Medical Letter on Drugs and Therapeutics • Sep 04, 2000 (Issue 1086)
a higher incidence of some adverse effects, such as insomnia, remains
to be established.
THE MEDICAL ...
Methylphenidate (Ritalin, and others) is now available in a new extended-release formulation (Concerta--Alza) for treatment of attention deficit/hyperactivity disorder (ADHD).
Caspofungin (Cancidas) For Aspergillosis
The Medical Letter on Drugs and Therapeutics • Jul 09, 2001 (Issue 1108)
to be established.
THE MEDICAL LETTER (ISSN 1523-2859) is published and printed in the USA bi-weekly ...
Caspofungin acetate(Cancidas) is the first of a new class of antifungals, the echinocandins. It has been approved by the FDA for treatment of invasive aspergillosis in patients who fail to respond to or are unable to tolerate other antifungal drugs such as amphotericin B and itraconazole.
Screening For Lung Cancer
The Medical Letter on Drugs and Therapeutics • Jul 23, 2001 (Issue 1109)
with
spiral CT could save lives remains to be established. Patients considering these scans should
be aware ...
Most patients with lung cancer present with advanced disease, and fewer than 20% live for five years after diagnosis. Earlier detection of lung cancer, when it is potentially resectable, might improve survival. Recent studies have led some radiology centers to promote spiral computed tomography (CT), which involves much less exposure to radiation than standard CT, as a screening tool for lung cancer.
Emergency Contraception OTC
The Medical Letter on Drugs and Therapeutics • Feb 02, 2004 (Issue 1175)
. Emergency contraception does not interfere with an established post-implantation pregnancy (DA Grimes and EG ...
An FDA Advisory Committee has recommended over-the-counter (OTC) marketing of Plan B (Barr), an emergency contraceptive "pill pack" that contains two 0.75-mg tablets of levonorgestrel to be taken 12 hours apart (Medical Letter 2000; 42:10). Plan B is one of two FDA-approved products for this indication. The Preven Emergency Contraceptive Kit (Medical Letter, 40:102, 1998) includes four tablets, each containing 0.25 mg of levonorgestrel and 50 ╡g of ethinyl estradiol; these are taken 2 at a time 12 hours apart (the "Yuzpe regimen") and are available only by...
Tadalafil (Cialis) Once a Day for Erectile Dysfunction
The Medical Letter on Drugs and Therapeutics • Apr 07, 2008 (Issue 1283)
, has been reported
rarely with all PDE5 inhibitors; cause and effect have
not been established.
LONG-TERM SAFETY ...
The phosphodiesterase type 5 (PDE5) inhibitor tadalafil (Cialis - Lilly) is now being promoted for once daily treatment of erectile dysfunction. Tadalafil differs from sildenafil (Viagra) and vardenafil (Levitra), the other PDE5 inhibitors marketed for erectile dysfunction in the US, in having a much longer duration of action.
Ezetimibe Revisited
The Medical Letter on Drugs and Therapeutics • Aug 25, 2008 (Issue 1293)
to
the magnitude of the LDL-C reduction. An effect on
carotid IMT, which is not as well established as a surrogate ...
In recent months, both the lay media and some medical experts have raised concerns about the effectiveness and safety of ezetimibe, a widely used drug that prevents absorption of cholesterol from the GI tract. Ezetimibe is available alone as Zetia and in combination with 10, 20, 40 and 80 mg of simvastatin (Zocor, and others) as Vytorin.
Intravenous Ibuprofen (Caldolor)
The Medical Letter on Drugs and Therapeutics • Jan 11, 2010 (Issue 1329)
surgery. Whether it offers any advantage over ketorolac (Toradol, and others) remains to be established ...
An intraveneous (IV) formulation of ibuprofen (Caldolor - Cumberland) was recently approved by the FDA for use in adults. It can be administered alone for treatment of mild to moderate pain or as an adjunct to opioid analgesics for moderate to severe pain. It is also approved for reduction of fever.
In Brief: Poor Metabolizers of Clopidogrel (Plavix)
The Medical Letter on Drugs and Therapeutics • May 03, 2010 (Issue 1337)
, but the
doses that would be safe and effective in such patients
have not been established. Alternatively ...
The FDA has required the manufacturer of Plavix, an antiplatelet drug used in addition to aspirin to prevent cardiovascular events in high-risk patients,1 to add a boxed warning to the package insert about the risk of a poor response to the drug in patients with genetic polymorphisms of the cytochrome P450 enzyme CYP2C19. Clopidogrel is a prodrug and CYP2C19 is mainly responsible for its bioactivation. The Medical Letter reported last year that several studies have found higher rates of cardiovascular events, including stent thrombosis, in patients with these polymorphisms taking...
Three New Drugs for Hereditary Angioedema
The Medical Letter on Drugs and Therapeutics • Aug 23, 2010 (Issue 1345)
prophylaxis remains to be established;
the androgens cost much less and can be
taken orally. The C1 esterase ...
In the past 2 years, the FDA has approved 3 new drugs for prevention or treatment of hereditary
angioedema (HAE) in non-pregnant adolescents and adults: the C1 esterase inhibitor Cinryze for prophylaxis and the C1 esterase inhibitor Berinert and the kallikrein inhibitor ecallantide (Kalbitor) for treatment of acute attacks.
Prothrombin Complex Concentrates to Reverse Warfarin-Related Bleeding
The Medical Letter on Drugs and Therapeutics • Oct 03, 2011 (Issue 1374)
, and
its effect on patient outcomes compared to PCC
remains to be established.
PROTHROMBIN COMPLEX ...
Warfarin-related bleeding, especially intracranial hemorrhage,
can be catastrophic. Several products are available
to reverse warfarin’s anticoagulant effect.